Lantern Pharma Company
Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical, Therapeutics
Industry:
AI, Drug Repurposing, United States
Headquarters:
Dallas, Texas, United States
Founded Date:
2013-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
4
Total Funding:
94980000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-01-14
Last Funding Type:
Post-IPO Secondary
Register and Claim Ownership